Point B Consulting

Point B is a private U.S. management consulting and technology services firm that works across multiple industries, including healthcare and life sciences. In health-related markets, the company advises payers, providers, and life sciences organizations on business transformation, digital and data strategy, clinical acceleration, portfolio management, AI readiness, commercialization support, and operational improvement. It is not a drug developer and does not appear to operate a therapeutic pipeline; instead, it provides consulting, execution, and managed technology services that help customers bring therapies to market faster and improve care delivery. The firm positions itself at the intersection of strategy, process, data, and technology, with particular emphasis on transformation programs and enterprise execution. For a biotech analyst, Point B is best understood as a services and advisory partner to healthcare and life sciences organizations rather than a biotech, pharma, or therapeutic-product company.